麻豆传媒

Philadelphia, PA USA

Our 麻豆传媒 on 麻豆传媒
View All >

The Perform Study: AI Versus Human Residents in Cross-Sectional Obstetrics-Gynecology Scenarios Across Languages and Time Constraints

The PERFORM Study: AI Versus Human Residents in Cross-Sectional Obstetrics-Gynecology Scenarios Across Languages and Time Constraints
27-Mar-2025 8:55 AM EDT Add to Favorites

Early Pandemic Vulnerability to Severe COVID Identified with Certain Immune System Genotypes

This updated analysis of the relationship between HLA and severe COVID looks at a 鈥榗ase-control鈥� study of HLA genotypes.
19-Mar-2025 5:45 PM EDT Add to Favorites

Precision Medicine Uses AI to Predict Protein Kinase Treatment Targets

Protein kinase research presents an opportunity to explore molecular targets in the body to treat diseases like cancer and autoimmune disorders. These enzymes have the potential to bind to cellular sites and inhibit dysfunctional behavior, such as...
10-Mar-2025 5:05 PM EDT Add to Favorites

An Important Step Forward in Precision Oncology: New Genetic Tool Predicts Chemotherapy Side Effects Before Treatment Begins

A groundbreaking pharmacogenetic tool has been developed and validated to predict chemotherapy side effects based on a patient鈥檚 genetic profile.
26-Feb-2025 5:20 AM EST Add to Favorites

Increasing Chemotherapy Effectiveness with Oleanolic Acid from Grapes

Researchers describe a new potential role for Oleanolic Acid as a modulator of the DNA damage response following Camptothecin treatment. Administration of Oleanolic Acid in combination with Camptothecin for cancer chemotherapy may reduce the amount...
27-Dec-2024 6:00 PM EST Add to Favorites

Falcons Exposed to Heavy Metals Are a Red Flag for Environmental Health

Exposure to heavy metals compromises immune functions and reduces reproductive success in the peregrine falcon (Falco peregrinus), according to a new paper published by researchers working with the Sbarro Health Research Organization (SHRO) at...
26-Nov-2024 3:00 PM EST Add to Favorites

麻豆传媒: 673b6ea12009b_6e40eae1-324c-4875-b674-026ecf111593.jpg

Maryland Professor Luana Colloca Recognized with Lifetime Achievement Award

The National Italian American Foundation (NIAF) and the Sbarro Health Research Organization (SHRO) named Dr. Luana Colloca the recipient of the 2024 Giovan Giacomo Giordano-NIAF Lifetime Achievement Award for Ethics and Creativity in Medical...
18-Nov-2024 10:55 AM EST Add to Favorites

Personalized Breast Cancer Treatment through Non-Invasive Liquid Biopsy

In patients with human epidermal growth factor receptor 2 (HER2)-low breast cancer, the molecular classification of their case plays a pivotal role in the formulation of personalized treatment plans aimed at optimizing outcomes. Despite notable...
14-Nov-2024 1:35 PM EST Add to Favorites


See All News

Our Experts on News

European Court Holds Italy Responsible for Environmental Hazards in 鈥淟and of Fires,鈥� SHRO鈥檚 Giordano Comments

17-Feb-2025 5:30 PM EST

Using Virtual Reality for Patient Support, SHRO鈥檚 Giordano Discusses

20-Sep-2022 8:05 AM EDT

Precision Medicine and the Anti-Cancer Properties of Foods like Green Tea, SHRO Founder Comments

2-Mar-2021 8:15 AM EST

Video Embedded
VIDEO

"We've got to get our act together" on public health measures to combat COVID, says Fauci

3-Nov-2020 2:35 PM EST

鈥楪enetic Shield鈥� May Explain Lower COVID Mortality in Southern Italy Compared to North

4-Jun-2020 9:55 AM EDT

Coronavirus: concern and precaution ok, but panic and hysteria unjustified, says expert

COVID-19 is similar in symptoms to the seasonal flu, but to recognize it there is a different procedure and we have to act accordingly
6-Mar-2020 8:20 AM EST

Cancer DNA Sequencing Has Potential, but Not a Magic Bullet, Says Expert

16-Jan-2018 11:05 AM EST

麻豆传媒: Slide1.jpg

Thorough Genotyping and Repurposed Drugs Key to Treating Small-Cell Lung Cancer, says Cancer Expert

Cancer expert Antonio Giordano, MD, PhD, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, describes the recent progress and future possibilities of treating SCLC.
13-Apr-2017 7:05 AM EDT

See All Experts

About

Sbarro Health Research Organization conducts research in cancer, diabetes, and cardiovascular disease. Based in Philadelphia, Pennsylvania on the campus of Temple University, our programs train young scientists from around the globe.

Experts

Twitter

Facebook

close
0.53118